A detailed history of Uma Financial Services, Inc. transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Uma Financial Services, Inc. holds 10 shares of HALO stock, worth $700. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10
Previous 22 54.55%
Holding current value
$700
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 04, 2025

SELL
$52.92 - $78.28 $635 - $939
-12 Reduced 54.55%
10 $0
Q2 2025

Jul 11, 2025

BUY
$47.91 - $70.14 $574 - $841
12 Added 120.0%
22 $1,000
Q1 2025

Apr 28, 2025

BUY
$47.74 - $65.16 $477 - $651
10 New
10 $0

Others Institutions Holding HALO

About HALOZYME THERAPEUTICS, INC.


  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $9.75B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track Uma Financial Services, Inc. Portfolio

Follow Uma Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Uma Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Uma Financial Services, Inc. with notifications on news.